Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Progression in Cholangiocarcinoma.
Loeuillard E, Li B, Stumpf HE, Yang J, Willhite J, Tomlinson JL, Wang J, Rohakhtar FR, Simon VA, Graham RP, Smoot RL, Dong H, Ilyas SI. Loeuillard E, et al. Among authors: dong h. bioRxiv [Preprint]. 2023 Jul 11:2023.05.24.541931. doi: 10.1101/2023.05.24.541931. bioRxiv. 2023. Update in: Cell Mol Gastroenterol Hepatol. 2024;17(5):853-876. doi: 10.1016/j.jcmgh.2024.01.006 PMID: 37293061 Free PMC article. Updated. Preprint.
Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Growth in Cholangiocarcinoma.
Loeuillard EJ, Li B, Stumpf HE, Yang J, Willhite JR, Tomlinson JL, Rohakhtar FR, Simon VA, Graham RP, Smoot RL, Dong H, Ilyas SI. Loeuillard EJ, et al. Among authors: dong h. Cell Mol Gastroenterol Hepatol. 2024;17(5):853-876. doi: 10.1016/j.jcmgh.2024.01.006. Epub 2024 Jan 14. Cell Mol Gastroenterol Hepatol. 2024. PMID: 38219900 Free PMC article.
TREM2 mediates MHCII-associated CD4+ T cell response against gliomas.
Zheng J, Wang L, Zhao S, Zhang W, Chang Y, Dheer A, Gao S, Xu S, Ayasoufi K, Al-Kharboosh R, Xie M, Johnson AJ, Dong H, Quiñones-Hinojosa A, Wu LJ. Zheng J, et al. Among authors: dong h. bioRxiv [Preprint]. 2023 Apr 6:2023.04.05.535697. doi: 10.1101/2023.04.05.535697. bioRxiv. 2023. Update in: Neuro Oncol. 2024 May 3;26(5):811-825. doi: 10.1093/neuonc/noad214 PMID: 37066234 Free PMC article. Updated. Preprint.
Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.
Kankeu Fonkoua LA, Chakrabarti S, Sonbol MB, Kasi PM, Starr JS, Liu AJ, Nevala WK, Maus RL, Bois MC, Pitot HC, Chandrasekharan C, Ross HJ, Wu TT, Graham RP, Villasboas JC, Weiss M, Foster NR, Markovic SN, Dong H, Yoon HH. Kankeu Fonkoua LA, et al. Among authors: dong h. Int J Cancer. 2021 Jul 15;149(2):378-386. doi: 10.1002/ijc.33559. Epub 2021 Mar 26. Int J Cancer. 2021. PMID: 33739449 Free PMC article.
11,266 results
You have reached the last available page of results. Please see the User Guide for more information.